This week in cardiology from heartwire

View all posts »

#174: Niacin/laropiprant products to be suspended; JNC 8, ATP 4 guidelines; new meta-analysis on sugar sparks old debate; two antihypertensives plus NSAID ups risk of acute kidney injury

Jan 18, 2013 14:50 EST


For the week ending January 18, 2013 we discuss the following top cardiology news from heartwire:

 

And also, in brief:

 

Join us for a comprehensive review of this week's most important cardiology news.





« Previous Post
#175: Apixaban approved: Now, which anticoagulant to use?; darbepoetin alfa disappoints in RED-HF; suspect thrombus with signs of early valve degeneration after TAVI; half of cardiology practices now integrated with hospitals
Jan 25, 2013 11:20 EST Next post »
#173: Exercise woefully underutilized; lesser degrees of excess weight don't increase mortality; FDA approves apixaban for stroke prevention in nonvalvular AF; fructose intake may contribute to overeating
Jan 11, 2013 14:40 EST




You must be a member (with full membership) to post a comment.
Already a member?
Enter your login information below:
 Remember me on this computer
Forgot your username and/or password?
        Login        
Enjoy all the benefits of theheart.org

With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.

Membership is free!

    Join now for full access